glp 1 medication what is it The Rise of GLP-1 Medications – Magnet List of approved and pending

It was also shown to be effective in patients without type 2 diabetes, supporting the therapeutic effects of SGLT2-i beyond diabetes [28]

There has also been clinical development of an analog known as CB4211, which appears in federal clinical trial records

These are neurotoxin induction-based models (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 6-hydroxydopamine (6-OHDA) and agricultural pesticides (rotenone, paraquat)), pharmacological models (reserpine or haloperidol treated rats), and genetic models (-synuclein, leucine-rich repeat kinase 2 (LRRK2), DJ-1, phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK-1) and Parkin)

Neha Pagidapati (Faculty at Duke University School of Medicine)